EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

Author: Davidson Ben   Goldberg Iris   Berner Aasmund   Kristensen Gunnar   Reich Reuven  

Publisher: Springer Publishing Company

ISSN: 0262-0898

Source: Clinical and Experimental Metastasis, Vol.20, Iss.2, 2003-03, pp. : 161-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content